Business Context and Reporting Period
Xtant Medical Holdings, Inc. (XTNT) filed this Form 8-K on March 2, 2026, reporting on events occurring on February 27, 2026. The filing details the final settlement of a divestiture transaction initiated on December 1, 2025, involving the sale of Coflex and CoFix product assets and the subsidiary Paradigm Spine GmbH to Companion Spine.
Key Financial Metrics
- Total Divestiture Proceeds: $21.4 million (final aggregate purchase price).
- Recent Cash Inflow: $10.7 million received on February 27, 2026.
- Debt Reduction: $2.8 million used to prepay a term loan with MidCap Financial Trust.
- Remaining Debt: $11.1 million principal outstanding on the term loan as of March 2, 2026.
- Previous Note Repayment: The $10.7 million payment included full repayment of an $8.2 million promissory note plus accrued interest and purchase price adjustments.
Material Changes
The primary material change is the finalization of the asset sale to Companion Spine. The total consideration increased from the initial $19.2 million to $21.4 million due to net working capital and other purchase price adjustments. Additionally, the company's debt load decreased by $2.8 million immediately following the receipt of funds.
Outlook and Management Commentary
Management confirmed the successful receipt of the final payment, which settled the outstanding promissory note and all purchase price adjustments. The company utilized a portion of the proceeds to reduce its leverage with MidCap Financial Trust. No forward-looking guidance or specific risk factors were disclosed in this specific filing beyond the completion of the transaction.
Investor Verification Checklist
- Verify the final aggregate purchase price of $21.4 million against the initial $19.2 million agreement.
- Confirm the remaining principal balance of $11.1 million on the MidCap Financial Trust term loan.
- Review the impact of the $2.8 million debt prepayment on the company's liquidity and interest expense.
- Assess the strategic implications of exiting the hardware business outside the United States via the Paradigm Spine GmbH sale.